Noscapine suppresses angiotensin converting enzyme inhibitors-induced cough

Nephrology

Volumn 10, Issue 4, 2005, Pages 348-350

  Mooraki, Ahmad ^a   Jenabi, Aria ^a   Jabbari, Mosadegh ^a   Zolfaghari, Mohammad I ^c   Javanmardi, Sahar Z ^c   Mahmoudian, Masoud ^b   Bastani, Bahar ^d  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Department of Electronic Engineer   (Iran)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin converting enzyme inhibitor; Cough; Hypertension; Noscapine

Indexed keywords

BRADYKININ; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; NOSCAPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DRUG INHIBITION; DRUG MECHANISM; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; INCIDENCE; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; TREATMENT WITHDRAWAL;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTITUSSIVE AGENTS; BRADYKININ; COUGH; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NOSCAPINE;

EID: 28444493591     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00429.x     Document Type: Article

References (19)

1. Sebastian JL, McKinney WP, Kaufman J, Young MJ. Angiotensin-converting enzyme inhibitors and cough: Prevalence in an outpatient medical clinic population. Chest 1991; 99: 36-9.
2. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann. Intern. Med. 1992; 117: 234-42.
3. Simon SR, Black HR, Moser M, Berland WE. Cough ACE inhibitors. Arch. Intern. Med. 1992; 152: 1698-700.
4. Morice AH, Lowry R, Brown MJ, Higenbottam T. Angiotensin-converting enzyme and the cough reflex. Lancet 1987; 2: 1116-18.
5. Gilchrist NL, Richards AM, March M, Nicholls MG. Effect of sulindac on angiotensin-converting enzyme inhibitor-induced cough: Randomized placebo-controlled double-blind cross-over study. J. Hum. Hypertens. 1989; 3: 451-5.
6. Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, Bames PJ. Bradykinin-evoked sensitization of airway sensory nerves: A mechanism for ACE-inhibitor cough. Nat. Med. 1996; 2: 814-17.
7. Cascieri MA, Bull. HG, Mumford RA, Patchett AA, Thornberry NA, Liang T. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422. Mol. Pharmacol. 1984; 25: 287-93.
8. Karlsoon MO, Dahlstrom B, Eckernas SA, Johansson M, Tufvesson AA. Pharmacokinetics of oral noscapine. Eur. J. Clin. Pharmacol. 1990; 39: 275-9.
9. Mahmoudian M, Mojaverian N. Effects of noscapine, the antitussive opioid alkaloid, on bradykinin-induced smooth muscle contraction in the isolated ileum of the guinea pig. Acta Physiol. Hungarica. 2001; 88: 231-7.
10. Ebrahimi SA, Zareie MR, Rostami P, Mahmoudian M. Interaction of noscapine with the bradykinin mediation of the cough response. Acta Physiol. Hungarica. 2003; 90: 147-55.
11. Aramori I, Zenkoh J, Morikawa N et al. Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor. Mol Pharmacol. 1997; 52: 16-20.
12. Katezung A. Basic and Clinical Pharmacology, 6th edn. Norwalk: Appleton & Lange, 1994.
13. Os I, Bartland B, Dahlof B, Gisholt K, Syvertsen JO, Tretli S. Female sex as an important determinant of lisinopril-induced cough. Lancet 1992; 339: 372.
14. Lee SC, Kim HS, Choi CH et al. Clinical characteristics and angiotensin converting enzyme gene polymorphism in the susceptibility to angiotensin converting enzyme inhibitor-induced cough. Korean Circ. J. 1996; 26: 1099-106.
15. Woo KS, Norris RM, Nicholls G. Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities). Am. J. Cardiol. 1995; 75: 967-8.
16. Lee SC, Park SW, Kim DK, Lee SH, Hong Y. Iron supplementation inhibits cough associated with ACE inhibitors. Hypertension 2001; 38: 166-70.
17. Hall JM. Bradykinin receptors: Pharmacological properties and biological roles. Pharmacy Ther. 1992; 56: 131-90.
18. Ricciardolo FLM, Geppetti P, Mistretta A et al. Randomized double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma. Lancet 1996; 348: 374-7.
19. Ellis KM, Fozard JR. Species differences in bradykinin receptor-mediated responses of the airways. Autono. Autacoid. Pharmacol. 2002; 22: 3-16.